company background image
NSCI

Nanalysis Scientific TSXV:NSCI Stock Report

Last Price

CA$0.42

Market Cap

CA$42.6m

7D

-7.6%

1Y

-43.3%

Updated

04 Dec, 2023

Data

Company Financials +

Nanalysis Scientific Corp.

TSXV:NSCI Stock Report

Mkt Cap: CA$42.6m

NSCI Stock Overview

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally.

NSCI fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health1/6
Dividends0/6

Nanalysis Scientific Corp. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nanalysis Scientific
Historical stock prices
Current Share PriceCA$0.42
52 Week HighCA$0.80
52 Week LowCA$0.40
Beta0.94
1 Month Change2.41%
3 Month Change-16.67%
1 Year Change-43.33%
3 Year Change0%
5 Year Changen/a
Change since IPO-22.73%

Recent News & Updates

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Aug 26
Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Recent updates

Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Aug 26
Would Nanalysis Scientific (CVE:NSCI) Be Better Off With Less Debt?

Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Apr 17
Nanalysis Scientific Corp.'s (CVE:NSCI) Price Is Right But Growth Is Lacking

Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Dec 08
Is Nanalysis Scientific (CVE:NSCI) Using Too Much Debt?

Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Jul 15
Is Nanalysis Scientific (CVE:NSCI) Weighed On By Its Debt Load?

Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Jan 24
Health Check: How Prudently Does Nanalysis Scientific (CVE:NSCI) Use Debt?

Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Mar 29
Is Nanalysis Scientific (CVE:NSCI) Using Debt Sensibly?

Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Dec 14
Nanalysis Scientific (CVE:NSCI) Has Debt But No Earnings; Should You Worry?

Shareholder Returns

NSCICA Medical EquipmentCA Market
7D-7.6%0.08%1.8%
1Y-43.3%-3.3%-2.0%

Return vs Industry: NSCI underperformed the Canadian Medical Equipment industry which returned -2.7% over the past year.

Return vs Market: NSCI underperformed the Canadian Market which returned -3% over the past year.

Price Volatility

Is NSCI's price volatile compared to industry and market?
NSCI volatility
NSCI Average Weekly Movement7.6%
Medical Equipment Industry Average Movement10.7%
Market Average Movement8.8%
10% most volatile stocks in CA Market18.0%
10% least volatile stocks in CA Market3.6%

Stable Share Price: NSCI is not significantly more volatile than the rest of Canadian stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: NSCI's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a249Sean Krakiwskyhttps://www.nanalysis.com

Nanalysis Scientific Corp. engages in the development, manufacture, and sale of magnetic resonance products in the United States, Canada, Europe, Asia, and internationally. The company operates through four segments: Nanalysis, RS2D, K’Prime, and Corporate. It offers nuclear magnetic resonance (NMR) spectrometers; software module packages; cutting-edge electronics components for precision analytical instruments; and services for its NMR technologies.

Nanalysis Scientific Corp. Fundamentals Summary

How do Nanalysis Scientific's earnings and revenue compare to its market cap?
NSCI fundamental statistics
Market CapCA$42.60m
Earnings (TTM)-CA$16.96m
Revenue (TTM)CA$25.87m

1.7x

P/S Ratio

-2.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
NSCI income statement (TTM)
RevenueCA$25.87m
Cost of RevenueCA$22.03m
Gross ProfitCA$3.84m
Other ExpensesCA$20.81m
Earnings-CA$16.96m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.17
Gross Margin14.85%
Net Profit Margin-65.58%
Debt/Equity Ratio61.2%

How did NSCI perform over the long term?

See historical performance and comparison